ASCO: Palliative and supportive care interventions increase...
Two studies presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting highlighted MD Anderson’s commitment to...
ASCO: Updated targeted therapy clinical trials results...
Updated results from two MD Anderson clinical trials presented at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting...
ASCO: Developing effective combination therapies for...
Findings from three studies led by researchers at MD Anderson suggest that new combination therapies are safe and effective against...
ASCO: Advances in T cell therapies for lymphomas
Two studies led by MD Anderson researchers explore advancements in CAR T cell therapy for non-Hodgkin lymphomas. CAR T cell therapy is...
ASCO: Studies pave the way on immunotherapy clinical trials...
Several MD Anderson-led studies at the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting focus on using immunotherapy...
ASCO: Emerging approaches to improve immunotherapy for...
Brian Odle has now overcome four cancer diagnoses in his life, thanks to inheriting a mutation in the TP53 gene. This inherited...
ASCO: Emerging targeted therapies show signs of clinical...
Julia Pitts tried all the standard treatment options with her local physicians after she was diagnosed with metastatic uterine cancer...
ASCO: Studies show advances in treatment and understanding...
Mutations in the BRCA 1 or 2 genes significantly increase an individual’s risk of developing breast cancer, as well as several other...
Study shows potential for digital microscopy for real-time...
Strategies to procure high-quality core-needle biopsy (CNB) specimens are critical for making basic tissue diagnoses and for ancillary...